Filter
37
Filtered Results: 37
Text search:
Global
Pharma
Health
Fund
E.V.
Featured
Recommendations
2
New Publications
6
Language
Document type
No document type
22
Studies & Reports
6
Guidelines
4
Manuals
3
Situation Updates
2
Countries / Regions
India
2
Kenya
2
Global
2
Ghana
1
Uganda
1
Philippines
1
Cambodia
1
Bangladesh
1
Malawi
1
Eswatini/ Swaziland
1
Ukraine
1
Madagascar
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
14
Pharmacy & Technologies
6
Women & Child Health
5
Public Health
3
Clinical Guidelines
3
Toolboxes
HIV
5
Global Health Education
5
Pharmacy
4
COVID-19
2
Disability
1
Mental Health
1
TB
1
Specific Hazards
1
AMR
1
Caregiver
1
NTDs
1
NCDs
1
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Updated 28 December 2020
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Technical Update
HIV Treatment
July 2017
It outlines key achievements, needs and opportunities for intervention in the field of rehabilitation in Ukraine. The content of this document is a snapshot in time – not an in-depth analysis of the entire rehabilitation sector. The analysis focuses on rehabilitation policy and governance, service...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of ...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Key Features:
• Module Users: Disaster Management Trainers
• Training Targets: State Government and District
officials / Disaster Management Authorities / Disaster
Management Planners and Responders
• Training Duration: 5 working days (one week)
• Trainers Input: Multi-disciplinary
...
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
